Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 35 - Antineoplastic agents
Patents for A61P 35 - Antineoplastic agents (221,099)
11/2012
11/07/2012CN102766135A Dihydrofuran indenoane-imidazole salts compound and preparation method thereof
11/07/2012CN102766122A Derivatives of dihydroaurone, benzofuran and orange alkane, and uses thereof
11/07/2012CN102766111A 3,4-diaryl-1,2,5-selenadiazole derivative and its application
11/07/2012CN102766109A 2,3-diaryl thiazolidine-4-one/-thioketone compounds, oxides thereof and use thereof
11/07/2012CN102766103A 2-sulfo-4-amino-1-naphthol derivative and preparation method and application thereof
11/07/2012CN102766068A Halogenated salicyloyl arylamine compounds as well as preparation method and application thereof
11/07/2012CN102764438A Novel application of beta3 adrenoceptor agonist
11/07/2012CN102764437A Methoxsalen injection and preparation method thereof
11/07/2012CN102764428A Application of V-set and transmembrane domain containing 1 (VSTM1) protein in preparation of product for inhibiting leukemia cell proliferation
11/07/2012CN102764426A Scorpion venom protein polypeptide colon-targeted preparation and preparation method thereof
11/07/2012CN102764335A Traditional Chinese medicine composition for treating hepatic diseases
11/07/2012CN102764327A Method for extracting lemon bioflavonoids
11/07/2012CN102764324A Medicine composition for treating neoplastic diseases and improving immunity
11/07/2012CN102764323A Method for preparing medicine composition for treating neoplastic diseases and improving immunity
11/07/2012CN102764320A Psychotria sp. extract, and preparation method and antineoplastic application thereof
11/07/2012CN102764315A Medicine for treating goiter
11/07/2012CN102764311A Xiao Jin dispensible tablet and preparation method thereof
11/07/2012CN102764307A Granules for preventing and controlling liver cancer
11/07/2012CN102764275A Externally-applied traditional Chinese medicine for treating tumour and preparation method thereof
11/07/2012CN102764274A Method for extracting propolis
11/07/2012CN102764273A Method for purifying skin secretions of tailed amphibian ranodon sibiricus and application
11/07/2012CN102764270A Human body longevity factor supplement
11/07/2012CN102764263A Application of 5alpha-8alpha-ergosterol peroxide-6,22(E)-diene-3beta-alcohol to preparation of anti-tumor drug
11/07/2012CN102764260A Pharmaceutical composition of camptothecin derivative and preparation method thereof
11/07/2012CN102764259A Application of sanguinarine compound in preparation of drug for preventing and treating caner and pharmaceutical composition
11/07/2012CN102764243A Aspirin pulsed release pellets, its preparation and preparation method thereof
11/07/2012CN102764241A Freeze-dried pharmaceutical composition containing gemcitabine hydrochloride
11/07/2012CN102764236A Matrine granules and preparation method thereof
11/07/2012CN102764234A Topotecan hydrochloride targeted liposome preparation and preparation method thereof
11/07/2012CN102764233A Liposome injection of 3-amino-6-aryl-thieno[2,3-b]pyridine-2-methanamide derivatives and preparation technology thereof
11/07/2012CN102327279B Triptolide and lonicerin compatible medicine composition, preparation and application thereof
11/07/2012CN102258788B Targeted transmission assembly of adriamycin anticancer medicine and preparation method thereof
11/07/2012CN102233017B Method for extracting apple polyphenol by using cutinase, and application thereof
11/07/2012CN102225053B Vincristine nano targeting slow-release long-circulation liposome and preparation method thereof
11/07/2012CN102210668B Application of cantharidin and derivants thereof in preparation of tumor chemotherapy sensitivity enhancing medicine
11/07/2012CN102180826B Histone deacetylase inhibitor containing alpha amino acid structure and application thereof
11/07/2012CN102178245B Extraction method for folium mori dietary fibers
11/07/2012CN102133234B Medicines for treating gastric cancer prepared by toad peptide antibiotics
11/07/2012CN102125549B Dihydroporphin photosensitizer as well as preparation method and application thereof
11/07/2012CN102123710B Bicyclic triazole derivatives for treating tumors
11/07/2012CN102091320B Toad peptide antibiotics for preparing medicine for treating liver cancer
11/07/2012CN102085177B Reducible and degradable nano medicine-carrying micelle and preparation method thereof
11/07/2012CN102068428B Dihydroporphin photosensitizer and preparation and application thereof
11/07/2012CN102048699B Preparation method for sustained release microsphere of injection triptorelin acetate
11/07/2012CN102020648B 3-aryl-6-aryl-[1,2,4] triazol [4,3-b] pyridazine taken as cell proliferation inhibitor and application of cell proliferation inhibitor
11/07/2012CN101948458B Baicalein derivatives with antitumor activity and application thereof in medicines
11/07/2012CN101891814B Anti-osteopontin OPN monoclonal antibody and application thereof
11/07/2012CN101868447B Method of making and administering quinoline derivatives as anti-cancer agents
11/07/2012CN101827848B 2- [ (2-{phenylamino}-1H-pyrrolo [2, 3-d] pyrimidin-4-yl) amino] benzamide derivatives as iIGF-1R inhibitors for the treatment of cancer
11/07/2012CN101804207B New application of miR-223
11/07/2012CN101773465B Polymer micelle medicine carrying system using amino acid as stabilizing agent
11/07/2012CN101747300B Mutual prodrug and preparation method based on paclitaxel and nitrogen mustard
11/07/2012CN101687822B Di(arylamino)aryl compound
11/07/2012CN101678101B Pharmaceutical compositions capable of inducing apoptosis in tumour cells, useful for diagnosis and treatment of B-chronic lymphocytic leukemia
11/07/2012CN101671329B Indolylmaleimide compound substituted with 3-amino alcohol, preparation method and application thereof
11/07/2012CN101669941B Method for treating malignant tumors with joint medicament administration and anti-malignant tumor medicament
11/07/2012CN101583622B Inhibitors for disrupting the interaction of ubiquitination related enzymes and uses thereof
11/07/2012CN101497878B Polypeptide of specific efficient affinity membrane type I substrate metal protease (MT1-MMP), protein and use
11/07/2012CN101448802B Acrylamide derivative as histone deacetylase inhibitors for cancer treatment
11/07/2012CN101415422B Anti-cancer pharmaceutical composition
11/07/2012CN101255139B Method for synthesizing antitumor compound of diketopiperazine PJ147
11/07/2012CN101234117B Medical use of a pair of ginseng saponin aglycones and their mixture
11/07/2012CN101217946B Formulations of water insoluble or poorly water soluble drugs in lipidated glycosaminoglycan particles and their pharmaceutical use
11/07/2012CN101166719B Bcrp/abcg2 inhibitor
11/07/2012CN101134110B Q type non-viral vector and pharmaceutical composition containing the same
11/07/2012CN101066260B Coenzyme Q10 emulsion and its freeze dried emulsion and their preparation process
11/06/2012US8304416 Chromenone derivatives
11/06/2012US8304414 Pyrazole compounds useful as protein kinase inhibitors
11/06/2012US8304409 Nitrosated nonsteroidal antiinflammatory compounds, compositions and methods of use
11/06/2012US8304408 Wnt signaling inhibitors, and methods for making and using them
11/06/2012US8304381 Human prolactin antagonist-angiogenesis inhibitor fusion proteins
11/06/2012US8303957 Mutated immunogenic peptides derived from R9M, polynucleotides coding for same and therapeutic uses thereof
11/06/2012US8303933 Multicomponent assemblies having enhanced binding properties for diagnosis and therapy
11/06/2012US8303932 Multicomponent assemblies having enhanced binding properties for diagnosis and therapy
11/06/2012CA2558195C 11-hydroxy-5h-pyrrolo[2,1-c][1,4]benzodiazepin-5-one derivatives as key intermediates for the preparation of c2 substituted pyrrolobenzodiazepines
11/06/2012CA2545359C Compositions and methods for regulation of tumor necrosis factor-alpha
11/06/2012CA2450257C Method of determining a chemotherapeutic regimen based on glutathione-s-transferase pi expression
11/06/2012CA2412790C Liposomal antineoplastic drugs and uses thereof
11/06/2012CA2365533C Diagnosis and treatment of neuroectodermal tumors
11/06/2012CA2365532C Arpe-19 as a platform cell line for encapsulated cell-based delivery
11/01/2012WO2012149546A2 Small molecule trail gene induction by normal and tumor cells as an anticancer therapy
11/01/2012WO2012149528A1 Inhibitors of inducible form of 6-phosphofructose-2-kinase
11/01/2012WO2012149454A2 Tolerogenic synthetic nanocarriers coupled to cd1d-restricted antigens and methods of use
11/01/2012WO2012149452A1 Compounds, formulations, and methods of protein kinase c inhibition
11/01/2012WO2012149439A2 Il4/il13 binding repeat proteins and uses
11/01/2012WO2012149419A1 Selecting use of proteasome inhibitors based on nf-kb2 sequence
11/01/2012WO2012149416A2 Human myeloid derived suppressor cell cancer markers
11/01/2012WO2012149413A1 17α-HYDROXYLASE/C17,20-LYASE INHIBITORS
11/01/2012WO2012149364A1 Tumor associated vaccines and compositions for disrupting tumor-derived immunosuppression for use in combination cancer immunotherapy
11/01/2012WO2012149356A2 Anti-cd40 antibodies and methods of use
11/01/2012WO2012149308A1 Method of treating lymphoma using pyridopyrimidinone inhibitors of pi3k/mtor
11/01/2012WO2012149267A1 Drug therapy to inhibit chemotherapy-induced adverse effects and related pharmaceutical compositions, diagnostics, screening techniques and kits
11/01/2012WO2012149160A2 Viruses modified with unnatural moieties and methods of use thereof
11/01/2012WO2012148952A1 Microrna compounds and methods for modulating mir-21 activity
11/01/2012WO2012148889A1 Inhibitors of human apurinic/apyrimidinic endonuclease 1
11/01/2012WO2012148846A1 Combination of a phosphatidylinositol-3-kinase (pi3k) inhibitor and a mtor inhibitor
11/01/2012WO2012148775A1 Bicyclic pyridazine compounds as pim inhibitors
11/01/2012WO2012148538A2 Anti-endoglin antibodies and knockin mice expressing novel human/mouse chimeric endoglin
11/01/2012WO2012148140A2 Imidazole-based alkaloid derivatives which have angiogenesis inhibition and antioxidant effects and production method thereof
11/01/2012WO2012148046A1 Anticancer and cancer-sensitizing composition comprising rrp12 inhibitor
1 ... 259 260 261 262 263 264 265 266 267 268 269 270 271 272 273 274 275 276 277 278 279 ... 2211